NEJMÊÙ¶¯²ñ2003 Âè17²ó03/5/28 ¼Â»Ü A¥×¥ê¥ó¥È ôÅö: ¿¹Àî ¿¿Âç (morikawa-tky@umin.ac.jp)
Case 31-2001: A 70-Year-Old Woman with End-Stage Renal Disease and Cutaneous Ulcers
¡ÊVolume 345(15): 1119-1124¡Ë
¨¡¨¡¨¡Ëö´ü¿ÕÉÔÁ´¤ÇÈéÉæ¤ËÄÙá礬½Ð¸½¤·¤¿70ºÐ½÷À­¨¡¨¡¨¡

 
¡Ú´µ¼Ô¡Û70ºÐ½÷À­
¡Ú¼çÁʡ۸Ƶۺ¤Æñ¡¤ÈéÉæÄÙáç¤Î¿ȯ
¡Ú¸½ÉÂÎò¡Û
  ´µ¼Ô¤Ë¤Ï¡¤Ä¹Ç¯¤Ë¤ï¤¿¤ë2·¿ÅüǢɤδû±ý¤ÈÄĵìÀ­¿´¶Ú¹¼ºÉ¡¤CABG¤Î´û±ý¤¬¤¢¤ë¡¥¤Þ¤¿¡¤È¯ºîÀ­¿´Ë¼ºÙÆ°¡¤Ýµ·ìÀ­¿´ÉÔÁ´¤ÈËö¾¿·ì´É¾ã³²¤Î´û±ý¤¬¤¢¤ê¡¤¤Þ¤¿Ëö´ü¿ÕÉÔÁ´(ESRD)¤ËÂФ·¤ÆÊ¢ËìÆ©ÀϤ¬Æ³Æþ¤µ¤ì¤Æ¤¤¤ë¡¥Æþ±¡¤Î6¥ö·îÁ°¤«¤é¹³¶Å¸ÇÎÅË¡¤È¤·¤Æwarfarin¤¬³«»Ï¤µ¤ì¤¿¡¥Warfarin¤Îdose¤ÏºÇ¶á¤Þ¤ÇÊѹ¹¤µ¤ì¤Æ¤¤¤Ê¤«¤Ã¤¿¡¥
  Æþ±¡20ÆüÁ°¡¤ÈéÉæ¤Î²õ»à¤ÈÁ«±ä¤¹¤ëȯǮ¤ò¼çÁʤ˾±¡¤ò¼õ¿Ç¡¥warfarin¤¬°ìöÃæ»ß¤µ¤ì¡¤low-molecular-weight heparin¤¬³«»Ï¤µ¤ì¤¿¡¥¤³¤Î»þÅÀ¤Ç·ìÇݱ¢À­¡¥UCG¤Ë¤Æ´¶À÷À­¿´ÆâËì±ê¤òµ¿¤ï¤»¤ë½ê¸«¤Ïǧ¤á¤é¤ì¤Ê¤«¤Ã¤¿¡¥ÈéÉæÀ¸¸¡¤Ë´Ø¤·¤Æ¤Ï¡¤´µ¼Ô¤ÎƱ°Õ¤¬ÆÀ¤é¤ì¤Ê¤«¤Ã¤¿¤¿¤á»Ü¹Ô¤µ¤ì¤Ê¤«¤Ã¤¿¡¥¶É½êŪ¤Ësilver sulfadiazine dressing (SSD)¤¬ÅÉÉÛ¤µ¤ì¡¤ceftriaxone¤Èampicillin-sulbactam¤¬Á´¿ÈÅêÍ¿¤µ¤ì¤¿¡¥Æ©ÀϤΥ«¥Æ¡¼¥Æ¥ëÇÝÍܤ«¤écoagulase-negative Staphylococcus aureus¤¬¸¡½Ð¤µ¤ì¤¿¤¿¤á¡¤vancomycin¤¬ÅêÍ¿¤µ¤ì¤¿¡¥
  Â¾±¡Æþ±¡17ÆüÌÜ(Æþ±¡3ÆüÁ°)¡¤´µ¼Ô¤Ï¥ê¥Ï¥Ó¥êɱ¡¤Ëž±¡¤·¤¿¡¥¤·¤«¤·¤½¤Îº¢¤«¤é¸«Åö¼±¾ã³²¤¬Ç§¤á¤é¤ì¤ë¤è¤¦¤Ë¤Ê¤ê¡¤¥Ç¡¼¥¿¾åABG¤Ë¤ÆpH 7.5¡¤PaO2 52 mmHg¡¤PaCO2 40 mmHg¤Ç¤¢¤Ã¤¿¡¥´µ¼Ô¤ÏMGH¤ËÈÂÁ÷¤µ¤ì¡¤¤½¤Î¤Þ¤Þ¶ÛµÞÆþ±¡¤È¤Ê¤Ã¤¿¡¥
 
¡Ú´û±ýÎò¡Û
type 2 DM¡¤OMI¡¤CABG(3 vessels)¡¤PAf¡¤CHF¡¤Ëö¾¿·ì´É¾ã³²¡¤ESRD(PDƳÆþ)
¡ÚÀ¸³èÎò¡Ûalcohol (-), cigarettes (-)
¡ÚÉþÌôÎò¡Ûatenolol¡¤insulin¡¤diltiazem¡¤epoetin (EPO)¡¤amiodarone¡¤lisinopril¡¤pravastatin¡¤isosorbide
 
 
¡ÚÆþ±¡»þ¸½¾É¡Û
<VITAL SIGNS> BT 38.2 ¡î, BP 160/? mmHg, PR 65 /min reg., RR 35 /min, SpO2 92 %(O2 4l/min), somnolent but could be aroused to speak a few words, orientation: time(-) space(-) person(+)
<LUNG> normal vesicular sound, no crackles
<HEART> systolic murmur (Levine ­¶/­º)
<LYMPHATICS> not swollen
<SKIN> ²¼»Þ¤Ë¿¿ô¤ÎÄÙá礬ǧ¤á¤é¤ì¤ë¡¥ºÇÂç·Â10 cm°Ê¾å¡¥¹õ¿§áÐÈé¤òÍ­¤·¡¤ÄÙáçÉô¤«¤é0.5-1.0 cmÄøÅ٤μþÊÕÉô¤Ç¤Ï¹Å²½À­¹ÈÈÃÍͤˤʤäƤ¤¤ë¡¥ÆýÎØÉôʬ¤Ë¤â¾®ÄÙá礬ǧ¤á¤é¤ì¤ë¡¥pus(-)
<EXTREMITIES> pulselessness(+), paleness(-) & warm
 
¡ÚÆþ±¡»þ¸¡ºº½ê¸«¡Û
<CBC> WBC 14.4¡ß103/mm3 (Neu 73 %, Eos 2 %, Baso 1 %, Mono 4 %, Lym 20 %), MCV 89 ¦Ìm3, Ht 32.6%, Plt 56.0¡ß104/mm3
<CHEMISTRY> TP 5.9 g/dl, Alb 1.4 g/dl, Glb 4.5 g/dl, LDH 422 IU/l, AST(GOT) 46 IU/l, ALP 407 IU/l, T.Bil: w.n.l., D.Bil: w.n.l., CK: w.n.l., Troponin I: w.n.l., BUN 53 mg/dl, Cre 5.4 mg/dl, UA: w.n.l., Na 134 mEq/l, K 3.9 mEq/l, Cl 96 mEq/l, Ca 9.2 mg/dl(ionized Ca 1.17 mmol/l: w.n.l.), iP 2.4 mg/dl, CO2 29.7 mmol/l, Glu 172 mg/dl
<ABG> (room air) pH 7.5, PaO2 54 mmHg, PaCO2 40 mmHg
<COAGULATION> PT 13.9 sec., PTT: w.n.l., ESR 128 mm/hr, Fib 949 mg/dl, D-Dimer 0.5-2.0 ¦Ìg/ml
<U/A> yellow, turbid, Pro(+++), Ket(+), RBC&WBC: innumerable/LPF, bacteria: large number/HPF
<ECG> intraventricular block, prolonged QT interval, diffuse nonspecific ST-segment and T-wave abnormalities
<CXR> cardiomegaly(+), lung fields: patchy atelectasis, aorta: tortuous
<²¼»èUS> deep venous thrombosis(-)
 
Æþ±¡¸å¡¤¤¢¤ë¿ÇÃÇŪ¼êµ»¤¬»Ü¹Ô¤µ¤ì¤¿¡¥